PITX1 as a grading, prognostic and tumor-infiltrating immune cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis
PITX1 is a novel biomarker for distinguishing between high-grade and low-grade CHS, serving as a prognostic indicator for patients with this condition and presenting a promising target for immunotherapy. These findings offer innovative insights into the treatment of CHS.
Authors
- Shubiao Chen
- Dongchen Liu (ORCID: https://orcid.org/0000-0002-7773-2520)
- Weiqing Lu
- Lan Hu
- Jinghao Zhang (ORCID: https://orcid.org/0009-0006-6678-1868)
- Zhang Ying (ORCID: https://orcid.org/0000-0002-1166-5935)
- Lei Xie
- Zikun Huang
Institutions
- Shantou University (CN)
- Cancer Hospital of Shantou University Medical College (CN)
- First Affiliated Hospital of Shantou University Medical College (CN)
- Shantou University Medical College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-11
- DOI
- https://doi.org/10.3389/fonc.2025.1477649
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00